Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification
Polycystic ovary syndrome (PCOS) is among the most common disorders in women of
reproductive age, affecting up to 15% worldwide, depending on the diagnostic criteria …
reproductive age, affecting up to 15% worldwide, depending on the diagnostic criteria …
Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls
SF Witchel, SE Oberfield, AS Peña - Journal of the Endocrine …, 2019 - academic.oup.com
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by
hyperandrogenism and chronic anovulation. Depending on diagnostic criteria, 6% to 20% of …
hyperandrogenism and chronic anovulation. Depending on diagnostic criteria, 6% to 20% of …
[HTML][HTML] Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies
MA Sanchez-Garrido, M Tena-Sempere - Molecular metabolism, 2020 - Elsevier
Background Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among
reproductive age women. Although its cardinal manifestations include hyperandrogenism …
reproductive age women. Although its cardinal manifestations include hyperandrogenism …
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
HF Escobar-Morreale - Nature Reviews Endocrinology, 2018 - nature.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …
Epigenetic inheritance of polycystic ovary syndrome—challenges and opportunities for treatment
E Stener-Victorin, Q Deng - Nature Reviews Endocrinology, 2021 - nature.com
Polycystic ovary syndrome (PCOS) is the main cause of female infertility worldwide and is
associated with a substantially increased lifetime risk of comorbidities, including type 2 …
associated with a substantially increased lifetime risk of comorbidities, including type 2 …
Obesity and polycystic ovary syndrome
TM Barber, S Franks - Clinical endocrinology, 2021 - Wiley Online Library
The increased global prevalence of obesity over the last 40‐years has driven a rise in
prevalence of obesity‐related co‐morbidities, including polycystic ovary syndrome (PCOS) …
prevalence of obesity‐related co‐morbidities, including polycystic ovary syndrome (PCOS) …
Genetic basis of polycystic ovary syndrome (PCOS): current perspectives
Polycystic ovary syndrome (PCOS) is a common infertility disorder affecting a significant
proportion of the global population. It is the main cause of anovulatory infertility in women …
proportion of the global population. It is the main cause of anovulatory infertility in women …
Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies
TM Barber, P Hanson, MO Weickert… - Clinical Medicine …, 2019 - journals.sagepub.com
Polycystic ovary syndrome (PCOS) is a common female condition typified by reproductive,
hyperandrogenic, and metabolic features. Polycystic ovary syndrome is a genetic condition …
hyperandrogenic, and metabolic features. Polycystic ovary syndrome is a genetic condition …
Polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …
The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited
RL Rosenfield, DA Ehrmann - Endocrine reviews, 2016 - academic.oup.com
Polycystic ovary syndrome (PCOS) was hypothesized to result from functional ovarian
hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989–1995 …
hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989–1995 …